Rising costs from motorcycle crashes threaten trauma center stability as public dollars cover millions in preventable spending, study shows Key Takeaways Repeal of Michigan’s universal motorcycle helmet law was associated with a…




Rising costs from motorcycle crashes threaten trauma center stability as public dollars cover millions in preventable spending, study shows Key Takeaways Repeal of Michigan’s universal motorcycle helmet law was associated with a…


Low‑dose oral lithium may slow down Alzheimer’s-associated verbal memory loss, but more research is needed Lithium—a decades-old treatment for bipolar disorder—may hold potential neuroprotective benefits beyond mood stabilization. An exploratory clinical trial from the…


Rat study points to a brain region that may be involved in biasing decision-making processes to favor alcohol over alternative rewards. People with alcohol use disorders tend to prioritize alcohol over alternative rewards, and…


An increasing number of U.S. states are implementing or considering changes to psychedelics policies. To help improve policy discussions and provide baseline information to ground these debates, the authors of a new…


After a grueling year of chemotherapy, surgery, and radiation to treat breast cancer, Sadia Zapp was anxious — not the manageable hum that had long been part of her life, but something…


At around 2 a.m., 7-year-old twin brothers arrived at Mission Hospital in Asheville. Both had a fever, a cough, a rash, pink eye, and cold symptoms. The boys sat in one waiting…


Having less plaque in arteries did not protect women from chest pain or heart attack, finds a new study in the Circulation: Cardiovascular Imaging journal Research Highlights: Although women typically have less…


Self-driving LUMI-lab system combines AI and robotics to advance design and evaluation of lipid nanoparticles for mRNA delivery Integrating AI with advanced robotics to create self-driving labs (SDL) is a promising approach…


The Food and Drug Administration’s decision, made public on Feb. 10, 2026, to not review an application to approve Moderna’s proposed mRNA-based flu vaccine set off a firestorm of criticism from public…